image
Tarsus Pharmaceuticals, Inc. TARS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 44.08
3.35 %
$ 1.85 B
Market Cap
-16.33
P/E
Price Target Average
53.81%
Revenue Forecast Estimate
51.60%
EBIT Estimate
--30.88%
Net Income Estimate
41.98%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Tarsus Pharmaceuticals, Inc.
image
Wall Street analysts predict an average 1-year price target for TARS of $67.8 , with forecasts ranging from a low of $58 to a high of $84 .
TARS Lowest Price Target Wall Street Target
58 USD 31.58%
TARS Average Price Target Wall Street Target
67.8 USD 53.81%
TARS Highest Price Target Wall Street Target
84 USD 90.56%
Price
Max Price Target
Min Price Target
Average Price Target
90908080707060605050404030302020Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart TARS

image
$1.0b$1.0b$900.0m$900.0m$800.0m$800.0m$700.0m$700.0m$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart TARS

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)($350.0m)($350.0m)($400.0m)($400.0m)202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart TARS

image
$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)202120212022202220232023202420242025202520262026202720272028202820292029